Want to join the conversation?
Jerry Revich of Goldman Sachs asks about the Industrial segment margins in 2Q16, the impact of one-off items. $JEC said there are some unique benefits realized in the 1H15 and some unique negatives seen in 1H16. So, comparability figures are a bit more challenged in 1H15 to 1H16. Going forward comparability will be more favorable.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?